Molecular mechanism of dipeptide repeat protein production from hexanucleotide repeats in C9ORF72-related ALS and FTD
C9ORF72相关ALS和FTD中六核苷酸重复产生二肽重复蛋白的分子机制
基本信息
- 批准号:10378768
- 负责人:
- 金额:$ 35.82万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-07-01 至 2024-03-31
- 项目状态:已结题
- 来源:
- 关键词:AffectAmyotrophic Lateral SclerosisAntisense RNABiochemicalC9ORF72CRISPR screenCRISPR/Cas technologyCandidate Disease GeneCell NucleusCellsCytoplasmCytoplasmic InclusionCytosolDipeptidesDiseaseEventFrontotemporal DementiaGene-ModifiedGenesGeneticGenetic ScreeningGenomicsGoalsHumanInduced pluripotent stem cell derived neuronsInheritedIntronsKnock-outLinkMediatingMolecularNerve DegenerationNeurodegenerative DisordersNuclear ExportNuclear RNANucleotidesPathogenesisPathogenicityPathologicPathway interactionsPatientsPhenotypeProcessProductionProteinsRNARNA ProcessingRNA SplicingReading FramesRegulationRegulatory ElementReporterSeriesSystemTechniquesTechnologyTestingTherapeuticTissuesToxic effectTranslatingTranslationsUntranslated RNAbasefrontotemporal lobar dementia-amyotrophic lateral sclerosisgenome-wideinduced pluripotent stem cellinsightmRNA Precursornovelnucleocytoplasmic transportpreventprotein expressionresearch and developmentscreeningstem cell modeltherapeutic targettool
项目摘要
PROJECT SUMMARY
Hexanucleotide repeat expansion in a non-coding region of C9orf72 is the most common genetic cause of both
amyotrophic lateral sclerosis (ALS) and frontal temporal dementia (FTD). One potential pathogenic mechanism
is the aberrant accumulation of dipeptide repeat (DPR) proteins produced by repeat-associated non-AUG
(RAN) translation in all six reading frames (poly-GA, poly-GR, poly-PA, poly-PR and poly-PG) of both sense
and antisense RNAs. Abnormal cytoplasmic inclusions of these DPR proteins have been found in C9ORF72
patient tissues and cells. Several lines of evidence indicate that some forms of the DPR proteins can be
pathogenic, yet little is known how the DPRs are generated from the expanded repeats. The goal of this
proposal is to understand the molecular mechanisms and identify genetic modifiers of DPR production from
both sense and antisense repeats, combining the genome-scale CRISPR/Cas9 knockout screening technology
with biochemical and molecular approaches. We will primarily focus on two major steps of repeat RNA
processing that could influence the final protein expression level: RNA nuclear export and RAN translation. We
will dissect the molecular pathways of nuclear export for both sense and antisense repeats, what factors
mediate this process, and how this is affected by C9-mediated toxicity on nucleocytoplasmic transport. We will
decipher the molecular mechanisms of C9 RAN translation, and examine whether there are common modifiers
between sense and antisense repeats. Altogether, these studies can provide novel insights on how DPRs are
produced from C9 repeats and what approaches can be taken to prevent it. This will guide the development of
research tools to understand how DRPs contribute to the disease pathogenesis. It will also possibly provide
potential therapeutic targets to reduce DPR-mediated toxicity by inhibiting their production.
项目总结
C9orf72非编码区的六核苷酸重复扩增是导致这两种疾病最常见的遗传原因
肌萎缩侧索硬化症(ALS)和额叶颞叶痴呆(FTD)。一种潜在的致病机制
二肽重复序列(DPR)蛋白的异常积累是由重复相关的非AUG
(RAN)在两个正义的所有六个阅读框架(PolyGA、PolyGR、PolyPA、PolyPR和PolyPG)中的翻译
和反义RNA。在C9ORF72中发现了这些DPR蛋白的异常胞质包涵体
患者组织和细胞。几条证据表明,某些形式的DPR蛋白可以是
致病,但几乎不知道dprs是如何从扩增的重复序列中产生的。这样做的目的是
建议了解DPR产生的分子机制并确定遗传修饰物
正义和反义重复,结合基因组规模的CRISPR/Cas9基因敲除筛选技术
用生化和分子方法。我们将主要关注重复RNA的两个主要步骤
可能影响最终蛋白质表达水平的处理:RNA核输出和RAN翻译。我们
将剖析正义和反义重复的核出口的分子途径,哪些因素
调节这一过程,以及C9介导的核质转运毒性如何影响这一过程。我们会
破译C9 RAN翻译的分子机制,并检查是否有共同的修饰因素
在正义和反义重复之间。总之,这些研究可以提供关于dprs是如何的新的见解。
由C9重复产生,以及可以采取什么方法来防止它。这将指导...的发展
研究工具,以了解DRP如何在疾病发病机制中做出贡献。它还可能提供
潜在的治疗靶点,通过抑制DPR的产生来减少DPR介导的毒性。
项目成果
期刊论文数量(6)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Measuring Repeat-Associated Non-AUG (RAN) Translation.
测量重复相关的非 AUG (RAN) 翻译。
- DOI:10.1007/978-1-0716-1975-9_8
- 发表时间:2022
- 期刊:
- 影响因子:0
- 作者:Wang,Shaopeng;Sun,Shuying
- 通讯作者:Sun,Shuying
Translation dysregulation in neurodegenerative diseases: a focus on ALS.
- DOI:10.1186/s13024-023-00642-3
- 发表时间:2023-08-25
- 期刊:
- 影响因子:15.1
- 作者:Wang, Shaopeng;Sun, Shuying
- 通讯作者:Sun, Shuying
DDX3X overexpression decreases dipeptide repeat proteins in a mouse model of C9ORF72-ALS/FTD.
DDX3X 过表达会减少 C9ORF72-ALS/FTD 小鼠模型中的二肽重复蛋白。
- DOI:10.1016/j.expneurol.2024.114768
- 发表时间:2024
- 期刊:
- 影响因子:5.3
- 作者:Fu,Xiujuan;Zhang,Zhe;Hayes,LindseyR;Wright,Noelle;Asbury,Julie;Li,Shelley;Ye,Yingzhi;Sun,Shuying
- 通讯作者:Sun,Shuying
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Shuying Sun其他文献
Shuying Sun的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Shuying Sun', 18)}}的其他基金
Dysregulation of inhibitory synapse by poly-GR in C9ORF72-ALS/FTD
C9ORF72-ALS/FTD 中 Poly-GR 抑制性突触失调
- 批准号:
10190158 - 财政年份:2021
- 资助金额:
$ 35.82万 - 项目类别:
C9orf72 hexanucleotide repeat expansion caused neurodegeneration in ALS and FTD
C9orf72 六核苷酸重复扩增导致 ALS 和 FTD 中的神经变性
- 批准号:
9324797 - 财政年份:2016
- 资助金额:
$ 35.82万 - 项目类别:
Mechanisms of C9orf72 hexanucleotide repeat expansion caused neurodegeneration in ALS and FTD
C9orf72 六核苷酸重复扩增导致 ALS 和 FTD 神经变性的机制
- 批准号:
8869891 - 财政年份:2015
- 资助金额:
$ 35.82万 - 项目类别:
Mechanisms of C9orf72 hexanucleotide repeat expansion caused neurodegeneration in ALS and FTD
C9orf72 六核苷酸重复扩增导致 ALS 和 FTD 神经变性的机制
- 批准号:
9014571 - 财政年份:2015
- 资助金额:
$ 35.82万 - 项目类别:
相似海外基金
Amyotrophic Lateral Sclerosis: treating the circuit behind the disease
肌萎缩侧索硬化症:治疗疾病背后的回路
- 批准号:
MR/Y014901/1 - 财政年份:2024
- 资助金额:
$ 35.82万 - 项目类别:
Research Grant
Dysregulation of RNA processing as a driver of motor neuron dysfunction in Amyotrophic Lateral Sclerosis
RNA 加工失调是肌萎缩侧索硬化症运动神经元功能障碍的驱动因素
- 批准号:
MR/Y014286/1 - 财政年份:2024
- 资助金额:
$ 35.82万 - 项目类别:
Research Grant
Fasciculation IN Amyotrophic Lateral Sclerosis Using MUMRI (FINALSUM)
使用 MUMRI 治疗肌萎缩侧索硬化症的肌束颤动 (FINALSUM)
- 批准号:
MR/Y503502/1 - 财政年份:2024
- 资助金额:
$ 35.82万 - 项目类别:
Research Grant
I-Corps: Developing A Blood-Based Biomarker for the Detection and Monitoring of Amyotrophic Lateral Sclerosis
I-Corps:开发一种基于血液的生物标志物,用于检测和监测肌萎缩侧索硬化症
- 批准号:
2317745 - 财政年份:2023
- 资助金额:
$ 35.82万 - 项目类别:
Standard Grant
Development of CM-CS1 CAR Treg to Treat Amyotrophic Lateral Sclerosis (ALS)
开发 CM-CS1 CAR Treg 治疗肌萎缩侧索硬化症 (ALS)
- 批准号:
10696512 - 财政年份:2023
- 资助金额:
$ 35.82万 - 项目类别:
Targeted immunotherapy for amyotrophic lateral sclerosis and frontotemporal dementia
肌萎缩侧索硬化症和额颞叶痴呆的靶向免疫治疗
- 批准号:
10759808 - 财政年份:2023
- 资助金额:
$ 35.82万 - 项目类别:
Metrics for Brain Controlled Communication: A comprehensive review of clinical outcome assessments for communication brain computer interfaces in amyotrophic lateral sclerosis
脑控制通信指标:肌萎缩侧索硬化症通信脑机接口临床结果评估的全面综述
- 批准号:
10848139 - 财政年份:2023
- 资助金额:
$ 35.82万 - 项目类别:
Resolving the Role of Neuronal STING in Amyotrophic Lateral Sclerosis and Frontotemporal Dementia
解决神经元 STING 在肌萎缩侧索硬化症和额颞叶痴呆中的作用
- 批准号:
10606865 - 财政年份:2023
- 资助金额:
$ 35.82万 - 项目类别:
The Gut Microbiota as a Contributor to Sexual Dimorphism in Amyotrophic Lateral Sclerosis
肠道微生物群是肌萎缩侧索硬化症性别二态性的一个促成因素
- 批准号:
488892 - 财政年份:2023
- 资助金额:
$ 35.82万 - 项目类别:
Operating Grants
The biochemical stratification of amyotrophic lateral sclerosis
肌萎缩侧索硬化症的生化分层
- 批准号:
MR/Y001095/1 - 财政年份:2023
- 资助金额:
$ 35.82万 - 项目类别:
Fellowship